Cleared Traditional

K061131 - DBX-H HEMOSTATIC DEMINERALIZED BONE MATRIX PUTTY (FDA 510(k) Clearance)

Feb 2007
Decision
290d
Days
Class 2
Risk

K061131 is an FDA 510(k) clearance for the DBX-H HEMOSTATIC DEMINERALIZED BONE MATRIX PUTTY. This device is classified as a Filler, Bone Void, Osteoinduction (w/o Human Growth Factor) (Class II - Special Controls, product code MBP).

Submitted by Orthocon, Inc. (Colts Neck, US). The FDA issued a Cleared decision on February 8, 2007, 290 days after receiving the submission on April 24, 2006.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3045.

Submission Details

510(k) Number K061131 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 24, 2006
Decision Date February 08, 2007
Days to Decision 290 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code MBP — Filler, Bone Void, Osteoinduction (w/o Human Growth Factor)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3045